🇺🇸 FDA
Patent

US 10980847

Compositions and methods for detecting and treating brain injury associated fatigue and altered cognition (BIAFAC)

granted A61KA61K2035/115A61K35/741

Quick answer

US patent 10980847 (Compositions and methods for detecting and treating brain injury associated fatigue and altered cognition (BIAFAC)) held by The Board of Regents of the University of Texas System expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K2035/115, A61K35/741, A61K9/0031, A61K9/0053